Bausch Health Companies (BHC) Non-Current Deffered Revenue (2009 - 2012)

Bausch Health Companies' (BHC) quarterly Non-Current Deffered Revenue came in at $36.1 million in Q4 2012, down 5.31% year-on-year from $38.2 million in Q1 2012, and down 1.63% quarter-over-quarter from $36.7 million in Q3 2012.

Bausch Health Companies (BHC) Non-Current Deffered Revenue (2009 - 2012) Analysis & Trends

Bausch Health Companies has disclosed Non-Current Deffered Revenue across 4 years of filings, most recently posting $36.1 million for Q4 2012.

  • Non-Current Deffered Revenue for Q4 2012 came in at $36.1 million, down 5.31% year-over-year; the trailing twelve-month figure through Dec 2012 was $36.1 million (down 5.31% YoY), and the FY2012 annual result was $36.1 million, down 5.31% from the prior year.
  • Non-Current Deffered Revenue came in at $36.1 million for Q4 2012 at Bausch Health Companies, down from $36.7 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $69.2 million in Q4 2009 to a low of $34.0 million in Q1 2012.
  • The 4-year median for Non-Current Deffered Revenue is $42.0 million (2011), against an average of $45.5 million.
  • Across the five-year window, Non-Current Deffered Revenue declined 28.5% in 2011 and slipped 5.31% in 2012, its largest moves.
  • Bausch Health Companies' Non-Current Deffered Revenue stood at $69.2 million in 2009, then declined by 27.76% to $50.0 million in 2010, then dropped by 23.73% to $38.2 million in 2011, then dropped by 5.31% to $36.1 million in 2012.
  • The last three Non-Current Deffered Revenue figures came in at $36.1 million (Q4 2012), $36.7 million (Q3 2012), and $37.9 million (Q2 2012), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Bausch Health Companies 1.93 Bn 1.59 Bn 2.48 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2012 36.13 Mn
Sep 30, 2012 36.73 Mn
Jun 30, 2012 37.90 Mn
Mar 31, 2012 33.97 Mn
Dec 31, 2011 38.15 Mn
Sep 30, 2011 41.41 Mn
Jun 30, 2011 42.51 Mn
Mar 31, 2011 45.02 Mn
Dec 31, 2010 50.02 Mn
Sep 30, 2010 55.03 Mn
Jun 30, 2010 59.45 Mn
Dec 31, 2009 69.25 Mn